Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929638-22-001843
Filing Date
2022-12-16
Accepted
2022-12-16 17:21:41
Documents
1
Group Members
NSV PARTNERS II, LLCNSV PARTNERS III GP, LLCNSV PARTNERS III, LPSOMASUNDARAM SUBRAMANIAM

Document Format Files

Seq Description Document Type Size
1 schedule13da.htm SC 13D/A 251908
  Complete submission text file 0000929638-22-001843.txt   253562
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92974 | Film No.: 221468922
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830
Business Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830 2126885100
NSV Investments I, L.P. (Filed by) CIK: 0001889184 (see all company filings)

EIN.: 352613353 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A